MIFH
INO icon

Migdal Insurance & Financial Holdings’s Inovio Pharmaceuticals INO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,514
Closed -$503K – 628
2021
Q1 		$503K Buy
4,514
+2,801
+164% +$368K 0.01% 319
2020
Q4 		$182K Buy
+1,713
New +$228K ﹤0.01% 329

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Migdal Insurance & Financial Holdings's INO Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 4,514 shares — an estimated $503K sold.

Migdal Insurance & Financial Holdings first reported a position in INO in Q4 2020 and held it in 2 quarters. The position peaked at $503K in Q1 2021. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 4,514 Inovio Pharmaceuticals shares in Q2 2021, an estimated $503K.
  • Migdal Insurance & Financial Holdings first reported a position in Inovio Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Inovio Pharmaceuticals position peaked at $503K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.